Financial regulation for sub-biobanks15 September 2020
Sub-biobanks are not required to pay up-front for the processing and storage of biomaterials. The effectiveness of this pre-financing agreement however is dependent on adherence to the demands regarding delivery and processing according to the Radboud Biobank standard operating procedures.
Opt-out versus Opt-In Consent for Residual Samples17 October 2019
The Radboud Biobank will be conducting a 6-month feasibility study, as proposed by the Netherlands Federation of University Medical Centers (NFU), to evaluate the impact of migrating to a opt-in method, which requires explicit consent from the patient for use of the residual material.
Need a transfer agreement for external partners? For the transfer of biomaterial and/or data to an external partner a material and data transfer agreement (MTA/DTA) must be used.17 January 2019
For the transfer of biomaterial and/or data to an external partner a material and data transfer agreement (MTA/DTA) must be used.
Preparation and storage of tissue samples – Radboud Biobank28 August 2018
The Pathology department prepares and stores tissue from Radboudumc patients on a large scale. This is carried out in a uniform and well documented manner. Some of the tissue is stored in the Pathology department’s diagnostic archive and some is stored in the Radboud Biobank.